April 1, 2016

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

Attn: Suzanne Hayes

Re:	Premier Biomedical, Inc.
	Registration Statement on Form S-1 File No. 333-209125

 

Dear Ms. Hayes:

On behalf of Premier Biomedical, Inc. (the "Company'), we have filed today a Third Amended Registration Statement on Form S-1 for the Company to include updated financial statements.

Company Statements

· The Company is responsible for the adequacy and accuracy of the disclosure in the filing;

· Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

· The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

The letter attached hereto indicates the Company's agreement and affirmation of the above "Company Statements."

Please do not hesitate to contact me if you have any questions. Thank you for your time and attention to this matter.

Very truly yours,
CLYDE SNOW & SESSIONS
By:	/s/ Brian A. Lebrecht
	Brian A. Lebrecht

April 1, 2016

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

Attn: Suzanne Hayes

Re:	Premier Biomedical, Inc.
	Registration Statement on Form S-1 File No. 333-209125

 

Dear Ms. Hayes:

Premier Biomedical, Inc. (the "Company") hereby affirms and agrees with the following statements related to the comment response for the above-mentioned filing to be filed with the Commission on or about April 1, 2016:

Company's Statements

· The Company is responsible for the adequacy and accuracy of the disclosure in the filing;

· Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

· The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

Please do not hesitate to contact me if you have any questions. Thank you for your time and attention to this matter.

Sincerely,
By:	/s/ William A. Hartman
	William A. Hartman President